Who
Daniel S. Goldberger
Other role
Company insider
Files Form 4 as: Chief Executive Officer, electroCore; Chairman and Interim CEO, KORU Medical Systems; President and CEO, Milestone Scientific; Chief Executive Officer, Xtant Medical Holdings; Chief Executive Officer, Xcorporeal.
In numbers
- Trades disclosed
- 79
- Buys
- 36
- Sells
- 2
- Bought
- $1.2M
- Sold
- $1.3M
- Companies
- 5
- Companies where not an officer
- 0
- First trade
- 14 Nov 2006
- Last trade
- 23 Apr 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Apr 2026filed 12 Jun 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Sold | $544K80,000 at $6.80 | filing |
| 23 Apr 2026filed 12 Jun 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Sold | $544K80,000 at $6.80 | filing |
| 10 Apr 2026filed 14 Apr 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Sold | $97K16,072 at $6.02 | filing |
| 10 Apr 2026filed 14 Apr 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Sold | $97K16,072 at $6.02 | filing |
| 26 Jan 2026filed 28 Jan 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | $152K20,375 at $7.47 | filing |
| 26 Jan 2026filed 28 Jan 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | $152K20,375 at $7.47 | filing |
| 26 Jan 2026filed 28 Jan 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 2 Dec 2025filed 3 Dec 2025 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $4,8401,000 at $4.84 | filing |
| 11 Aug 2025filed 12 Aug 2025 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $4,2301,000 at $4.23 | filing |
| 17 Mar 2025filed 18 Mar 2025 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $8,5901,000 at $8.59 | filing |
| 18 Jan 2025filed 21 Jan 2025 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | ECOR electroCoreoption or derivative · Medical Devices | SEC FORM 4 Code P | $1,15519,252 at $0.06 | filing |
| 5 Jun 2024filed 6 Jun 2024 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $248K38,505 at $6.43 | filing |
| 16 Jan 2024filed 18 Jan 2024 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 15 Sep 2023filed 19 Sep 2023 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $8,3401,500 at $5.56 | filing |
| 4 Aug 2023filed 8 Aug 2023 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | —50,000 at $0.00 | filing |
| 2 Aug 2023filed 3 Aug 2023 | ECOR electroCoreoption or derivative · Medical Devices | SEC FORM 4 Code P | $1,53025,495 at $0.06 | filing |
| 2 Aug 2023filed 3 Aug 2023 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $222K50,991 at $4.35 | filing |
| 17 Mar 2023filed 20 Mar 2023 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $1,715500 at $3.43 | filing |
News
Enovis (NYSE:ENOV) and electroCore (NASDAQ:ECOR) Head to Head SurveyECOR · themarketsdaily.com · 11 Oct 2026Enovis (NYSE:ENOV) versus electroCore (NASDAQ:ECOR) Financial ContrastECOR · tickerreport.com · 9 Oct 2026
0 headlines in the last 90 days name Daniel S. Goldberger; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.